AbbVie Agrees to Acquire Nimble Therapeutics

Estimated read time 1 min read

This will bring Nimble’s psoriasis and inflammatory bowel disease treatment under AbbVie’s pipeline.

You May Also Like

More From Author

+ There are no comments

Add yours